Genpact Limited (G) — Analyst outlook / Analyst consensus target is. Based on 39 analyst ratings, the consensus is bullish — 19 Buy, 20 Hold.
The consensus price target is $46.00 (low: $42.00, high: $50.00), representing an upside of 29.6% from the current price $35.50.
Analysts estimate Earnings Per Share (EPS) of $3.23 and revenue of $4.75B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $2.88 vs est $3.23 (missed -10.9%). 2025: actual $3.18 vs est $3.62 (missed -12.1%). Analyst accuracy: 87%.
G Stock — 12-Month Price Forecast
$46.00
▲ +29.58% Upside
Average Price Target
Based on 39 Wall Street analysts offering 12-month price targets for Genpact Limited, the average price target is $46.00, with a high forecast of $50.00, and a low forecast of $42.00.
The average price target represents a +29.58% change from the last price of $35.50.
Highest Price Target
$50.00
Average Price Target
$46.00
Lowest Price Target
$42.00
G Analyst Ratings
Hold
Based on 39 analysts giving stock ratings to Genpact Limited in the past 3 months
EPS Estimates — G
87%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $2.88
vs Est $3.23
▼ 12.3% off
2025
Actual $3.18
vs Est $3.62
▼ 13.8% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is improving.
Revenue Estimates — G
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $4.767B
vs Est $4.747B
▲ 0.4% off
2025
Actual $5.080B
vs Est $5.069B
▲ 0.2% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
